Customer Focused Innovation: The Reverse Feasibility Program
An Interview with Denise Deakin, President & Co-Founder of Scimega Oncology

Denise-Deakin_Scimega-CROAs Canada's Premier Oncology CRO, Scimega has developed a unique approach to the conduct of oncology clinical trials and their sales & marketing strategy has been fuelled by a customer-centric program that solves a problem by connecting stakeholders through a network of priviledged relationships.

Listen, as Ms. Deakin talks about how the idea for the Reverse Feasibility Program came about in 2008 and why it has become not just a valuable operational tool but also how it sits at the core of their marketing strategy and how it clearly communicates the value it delivers for both drug developers as well as Canadian oncologists and their cancer patients. 

Time: 8:01 - Aired 04/27/2015